Long‐Term Outcome of Ustekinumab Therapy for Behçet's Disease-Reference-Cited by-同舟云学术

Long‐Term Outcome of Ustekinumab Therapy for Behçet's Disease

Published:2019-08-12 Issue:10 Volume:71 Page:1727-1732
ISSN:2326-5191
Container-title:Arthritis & Rheumatology
language:en
Short-container-title:Arthritis Rheumatol

Author:

Mirouse Adrien¹,Barete Stéphane²,Desbois Anne‐Claire¹,Comarmond Cloé¹,Sène Damien³,Domont Fanny¹,Bodaghi Bahram⁴,Ferfar Yasmina¹,Cacoub Patrice¹^ORCID,Saadoun David¹,

Affiliation:

1. Sorbonne UniversitéCentre National de Référence Maladies Auoimmunes Systémiques RaresCentre National de Référence Maladies Autoinflammatoires et Amylose InflammatoireINSERM 959, Groupe Hospitalier Pitié‐SalpêtrièreAP‐HP Paris France

2. Groupe Hospitalier Pitié‐SalpêtrièreAP‐HP, and Département Hospitalo‐Universitaire Inflammation‐Immunopathologie‐Biotherapie Paris France

3. Hôpital LariboisièreAP‐HP Paris France

4. Groupe Hospitalier Pitié‐SalpêtrièreAP‐HP Paris France

Publisher

Wiley

Subject

Immunology,Rheumatology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/art.40912

Reference28 articles.

1. Behçet's Disease

2. Behçet disease

3. 2018 update of the EULAR recommendations for the management of Behçet's syndrome;Hatemi G;Ann Rheum Dis,2018

4. Apremilast for Behçet’s Syndrome — A Phase 2, Placebo-Controlled Study

5. Modulation of CLA, IL-12R, CD40L, and IL-2Rα expression and inhibition of IL-12- and IL-23-induced cytokine secretion by CNTO 1275

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In Silico Target Identification Reveals IL12B as a Candidate for Small Molecule Drug Development;2024-09-07

2. Ustekinumab: In Psoriasis and Beyond —A Derm atological Perspective;Journal of Pharmacology and Pharmacotherapeutics;2024-05-08

3. Dimethyl itaconate inhibits antigen‐specific Th17 cell responses and autoimmune inflammation via modulating NRF2/STAT3 signaling;The FASEB Journal;2024-04-06

4. Recomendaciones SER sobre el tratamiento del síndrome de Behçet refractario;Reumatología Clínica;2024-04

5. SER recommendations on treatment of refractory Behçet's syndrome;Reumatología Clínica (English Edition);2024-04